[FOR IMMEDIATE RELEASE]
April 5, 2024
Holly Hill, FL – K2 Medical Research and MetroHealth Inc. are proud to announce their partnership in a groundbreaking venture: K2 Metro Research. This collaboration marks a significant step forward in integrating clinical research as a fundamental component of everyday healthcare practice, with the aim of reducing stigma and increasing accessibility to cutting-edge advancements in medical science.
Clinical research has long been perceived as an intimidating and distant field, but with K2 Metro Research, we aim to change that perception. By bringing clinical trials into the forefront of everyday healthcare, we are breaking barriers and creating a new standard for patient care.
“At K2 Metro Research, we believe in putting people first,” says Dr. Christopher Galloway, Principal Investigator at K2 Medical Research. “Our mission is to transform the clinical trial experience into one that prioritizes respect, compassion, and warmth. By partnering with MetroHealth Inc., we are bridging the gap between clinical research and everyday healthcare, making it a seamless and accessible option for patients.”
Santiago Santelis, MD, Site Director at K2 Metro Research, will oversee all operational aspects of the partnership, ensuring that clinical research is seamlessly integrated into the practice. “We are committed to providing our patients with the highest quality of care, and that includes access to the latest advancements in medical science,” says Dr. Santelis. “By partnering with MetroHealth Inc., we are able to reach a wider audience and make a positive impact on healthcare delivery in Holly Hill.”
Dr. Stephen Quaning and Samuel Dunlop, DNP, NP-C of MetroHealth Inc. will serve as sub-Investigators, while providing clinical care to patients participating in clinical trials. “We are thrilled to be part of this innovative partnership,” says Dr. Quaning. “By combining our expertise in patient care with K2 Medical Research’s knowledge in clinical trials, we are able to offer our patients a holistic approach to healthcare that addresses both their immediate medical needs and their long-term wellness goals.”
Through K2 Metro Research, patients will have access to the newest advancements in medical science, all while receiving compassionate and personalized care from MetroHealth Inc. healthcare providers. This initiative aims to not only improve patient outcomes but also to decrease the stigma behind participation in clinical trials by making it an integral part of everyday practice.
For more information about K2 Metro Research and how to get involved, visit K2med.com or contact Sandra Carmona Torres, BSN.
K2 Metro Research, Holly Hill
1852 Ridgewood Avenue, Holly Hill, FL 32117
407-378-6248
Santiago.Santelis@k2med.com
MEDIA CONTACT:
Sandra Torres, BSN
T: 407-818-1957
Christopher Galloway, MD is a board-certified Family Medicine physician with 20 years of clinical experience. Dr. Galloway joins K2 as an experienced Principal Investigator having participated in over 100 clinical trials over multiple therapeutic areas and specializing in Neurodegenerative trials. Dr. Galloway earned his undergraduate degree from the University of Utah and is a graduate of New York Medical College. He completed his residency at Florida Hospital (now AdventHealth). He is bilingual in English and Spanish.
Santiago Santelis, MD, MS, joins K2 as the Site Director for the Holly Hill location with over 15 years of clinical experience. Santiago has been published in several review articles, abstracts, and peer reviewed scientific journals related to the endocrine response to burns, and a proposal to standardize burn patient data. He is bilingual in English and Spanish.
MetroHealth is a network of primary care doctors and health professionals for seniors in Orange and Volusia County who are insured through Medicare. Our model is a throwback to the days of old, when a primary care physician would coordinate with specialists to provide you with the best comprehensive medical care available. At MetroHealth, we go out of our way to ensure that you get the expert medical care you need and the compassion you deserve. Our providers are your partners in health, and our mission is to help you enjoy life to the fullest.
K2 Medical Research, a privately-owned clinical research facility in the greater Central Florida area. We specialize in conducting multiphasic clinical trials that promote the development of innovative and effective medical treatments while maintaining the safety and privacy of our participants. Here at K2, we are committed to fighting the diseases that plague our loved ones and ourselves. By harnessing the power of advanced clinical research and connecting our patients with the treatments of tomorrow, we can improve the health of our local communities, and by extent, the population of our world.
